. 2019 Apr 1;25:2368–2376. doi: 10.12659/MSM.915474

Table 2.

The relationship between TRAF4, ki-67 and p53 expression and the clinicopathologic features in 100 ESCC patients(cases).

		Sum	TRAF4		χ²	P	Ki-67		χ²	P	p53		χ²	P
		Sum	High	Low	χ²	P	High	Low	χ²	P	High	Low	χ²	P
Gender	Male	74	66	8	3.917	0.048	46	28	0.162	0.688	47	27	0.277	0.599
Gender	Female	26	19	7	3.917	0.048	15	11	0.162	0.688	15	11	0.277	0.599
Age (years)	≤65	51	43	8	0.038	0.845	32	19	0.133	0.715	33	18	0.323	0.57
Age (years)	>65	49	42	7	0.038	0.845	29	20	0.133	0.715	29	20	0.323	0.57
Tumor size (cm)	≤5	56	46	10	0.005	0.944	31	25	0.353	0.553	36	20	0.668	0.414
Tumor size (cm)	>5	29	24	5	0.005	0.944	18	11	0.353	0.553	16	13	0.668	0.414
Lymphatic metastasis	Yes	54	49	5	3.21	0.073	39	15	5.65	0.017	34	20	0.006	0.94
Lymphatic metastasis	No	45	35	10	3.21	0.073	22	23	5.65	0.017	28	17	0.006	0.94
TNM stages	I/II	46	37	9	1.76	0.189	22	24	9.416	0.002	33	13	4.734	0.03
TNM stages	III	50	45	5	1.76	0.189	39	11	9.416	0.002	25	25	4.734	0.03
Pathological grading	I/II	72	61	11	0.016	0.901	40	32	3.204	0.073	43	29	0.566	0.452
Pathological grading	III	28	24	4	0.016	0.901	21	7	3.204	0.073	19	9	0.566	0.452